GenMark Diagnostics to offer 10M shares; Reconciled user fee bill comes up for House vote;

 @FierceMedDev: We have extended the nomination deadline for the 15 fiercest medical device developers to July 13. Spread the word. Survey | Follow @FierceMedDev

> Molecular diagnostics firm GenMark Diagnostics ($GNMK) is planning a public offering of 10 million shares, looking to use the money raised to develop more test offerings and expand its global reach. More

> CareFusion ($CFN) has signed a deal to link its Alaris infusion pumps to Epic's electronic medical reporting platform, allowing doctors to track issues and reduce errors. Item

> Boehringer Ingelheim has launched a study to evaluate whether Pradaxa is more effective than warfarin in patients with mechanical heart valves. News

> Cardiac Science, a Puget Sound, WA-area maker of automated external defibrillators and electrocardiac devices, has hired a new CEO. Story

> Bausch + Lomb has gained FDA approval for its enVista hydrophobic acrylic intraocular lens. Release

Biotech News

@FierceBiotech: Check out our live coverage of ‪BIO 2012‬ in Boston. More | Follow @FierceBiotech

@JohnCFierce: Tesaro sets IPO terms, looks to raise about $81M, with $25M maybe coming from insiders - I'd like to see this one work. More | Follow @JohnCFierce

@RyanMFierce: Thanks @Millennium_US, Shire, and Biogen for participating on our ‪BIO 2012‬ panel. We drew a crowd and covered a lot. | Follow @RyanMFierce

> Investors offer grim odds of success for two big Alzheimer's programs. Story

> Tesaro insiders pledge support for $86M IPO gamble. Article

> Biotech employment, salaries weather a stormy economic downturn. News

Pharma News

@FiercePharma: Daiichi to take over ‪Ranbaxy‬ unit's marketing in Venezuela, latest 'hybrid biz model' move to make buyout pay off. More | Follow @FiercePharma

> CSL confirms Fluvax manufacturing tied to convulsions in children. News

> Spanish drugmakers hold out their hats to government. More

> Icahn comes back at Forest with 4 board nominees. Story

Drug Delivery News

@DamianFierce: Drugmakers are rethinking drug delivery methods for multiple sclerosis treatments. Report | Follow @DamianFierce

> Notre Dame's nanoparticles effective against drug-resistant cancer. Story

> Ambrx nabs $303M deal with Merck for 'smart bomb' delivery. Article

> TheStreet: Alkermes should stick to drug delivery. More

> Explosive nanocarriers thwart target cells' defenses. News

Biomarkers News

> Blood test for pancreatic cancer may be possible. Story

> Huntington's disease marker emerges in clinical trial. News

> Biodesix feels the buzz at BIO2012. Article

And Finally... The U.S. House of Representatives is scheduled to vote June 20 on a bill that reconciles House and Senate user fee reauthorization bills, The Hill reports. Story